AAAAAA
Results: 101-125/568
Authors:
CANEVARI S
MEZZANZANICA D
MAZZONI A
NEGRI DRM
FIGINI M
RAMAKRISHNA V
BOLIS G
COLNAGHI MI
Citation: S. Canevari et al., APPROACHES TO IMPLEMENT BISPECIFIC ANTIBODY TREATMENT OF OVARIAN-CARCINOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 187-189
Authors:
WEINER LM
ALPAUGH RK
VONMEHREN M
Citation: Lm. Weiner et al., REDIRECTED CELLULAR CYTOTOXICITY EMPLOYING BISPECIFIC ANTIBODIES AND OTHER MULTIFUNCTIONAL BINDING-PROTEINS, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 190-192
Authors:
KUFER P
MACK M
GRUBER R
LUTTERBUSE R
ZETTL F
RIETHMULLER G
Citation: P. Kufer et al., CONSTRUCTION AND BIOLOGICAL-ACTIVITY OF A RECOMBINANT BISPECIFIC SINGLE-CHAIN ANTIBODY DESIGNED FOR THERAPY OF MINIMAL RESIDUAL COLORECTAL-CANCER, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 193-197
Authors:
MANZKE O
TITZER S
TESCH H
DIEHL V
BOHLEN H
Citation: O. Manzke et al., CD3-X-CD19 BISPECIFIC ANTIBODIES AND CD28 COSTIMULATION FOR LOCOREGIONAL TREATMENT OF LOW-MALIGNANCY NON-HODGKINS-LYMPHOMA, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 198-202
Authors:
KROESEN BJ
NIEKEN J
SLEIJFER DT
MOLEMA G
DEVRIES EGE
GROEN HJM
HELFRICH W
THE TH
MULDER NH
DELEIJ L
Citation: Bj. Kroesen et al., APPROACHES TO LUNG-CANCER TREATMENT USING THE CD3E-X-GP-2-DIRECTED BISPECIFIC MONOCLONAL-ANTIBODY BIS-1, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 203-206
Authors:
VANOJIK HH
REPP R
GROENEWEGEN G
VALERIUS T
VANDEWINKEL JGJ
Citation: Hh. Vanojik et al., CLINICAL-EVALUATION OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-FC-GAMMA-RI-X-ANTI-HER-2 NEU) IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOR TREATMENT OF ADVANCED BREAST-CANCER/, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 207-209
Authors:
CURNOW RT
Citation: Rt. Curnow, CLINICAL-EXPERIENCE WITH CD64-DIRECTED IMMUNOTHERAPY - AN OVERVIEW, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 210-215
Authors:
ASANO Y
KANEDA K
HIRAGUSHI J
TSUCHIDA T
HIGASHINO K
Citation: Y. Asano et al., THE TUMOR-BEARING STATE INDUCES AUGMENTED RESPONSES OF ORGAN-ASSOCIATED LYMPHOCYTES TO HIGH-DOSE INTERLEUKIN-2 THERAPY IN MICE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 63-70
Authors:
YUAN L
KOBAYASHI M
KURAMITSU Y
LI YG
MATSUSHITA K
HOSOKAWA M
Citation: L. Yuan et al., RESTORATION OF MACROPHAGE TUMORICIDAL ACTIVITY BY BLEOMYCIN CORRELATES WITH THE DECREASED PRODUCTION OF TRANSFORMING-GROWTH-FACTOR-BETA IN RATS BEARING KDH-8 HEPATOMA-CELLS, Cancer immunology and immunotherapy, 45(2), 1997, pp. 71-76
Authors:
KRUSE CA
CEPEDA L
OWENS B
JOHNSON SD
STEARS J
LILLEHEI KO
Citation: Ca. Kruse et al., TREATMENT OF RECURRENT GLIOMA WITH INTRACAVITARY ALLOREACTIVE CYTOTOXIC T-LYMPHOCYTES AND INTERLEUKIN-2, Cancer immunology and immunotherapy, 45(2), 1997, pp. 77-87
Authors:
VANHAL NLW
VANDONGEN GAMS
TENBRINK CBM
HERRON JN
SNOW GB
BRAKENHOFF RH
Citation: Nlw. Vanhal et al., SEQUENCE VARIATION IN THE MONOCLONAL-ANTIBODY-U36-DEFINED CD44V6 EPITOPE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 88-92
INTRAPLEURAL INSTILLATION OF INTERFERON-GAMMA IN PATIENTS WITH MALIGNANT PLEURISY DUE TO LUNG-CANCER
Authors:
YANAGAWA H
HAKU T
HIRAMATSU K
NOKIHARA H
TAKEUCHI E
YANO S
HANIBUCHI M
SONE S
Citation: H. Yanagawa et al., INTRAPLEURAL INSTILLATION OF INTERFERON-GAMMA IN PATIENTS WITH MALIGNANT PLEURISY DUE TO LUNG-CANCER, Cancer immunology and immunotherapy, 45(2), 1997, pp. 93-99
Authors:
LASEK W
FELESZKO W
GOLAB J
STOKLOSA T
MARCZAK M
DABROWSKA A
MALEJCZYK M
JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 100-108
Authors:
EVERAUS H
LUIK E
LEHTMAA J
Citation: H. Everaus et al., ACTIVE AND INDOLENT CHRONIC LYMPHOCYTIC-LEUKEMIA - IMMUNE AND HORMONAL PECULIARITIES, Cancer immunology and immunotherapy, 45(2), 1997, pp. 109-114
Authors:
CLARKE GR
BURTON RC
SMART YC
Citation: Gr. Clarke et al., THE ANTITUMOR EFFECTS OF LEVAMISOLE IN MICE ARE MEDIATED BY NC-1.1+ CELLS, Cancer immunology and immunotherapy, 45(2), 1997, pp. 115-118
Authors:
BELLI F
ARIENTI F
SULESUSO J
CLEMENTE C
MASCHERONI L
CATTELAN A
SANTANTONIO C
GALLINO GF
MELANI C
RAO S
COLOMBO MP
MAIO M
CASCINELLI N
PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997), Cancer immunology and immunotherapy, 45(2), 1997, pp. 119-119
Authors:
LIVINGSTON PO
ZHANG SL
LLOYD KO
Citation: Po. Livingston et al., CARBOHYDRATE VACCINES THAT INDUCE ANTIBODIES AGAINST CANCER .1. RATIONALE, Cancer immunology and immunotherapy, 45(1), 1997, pp. 1-9
CARBOHYDRATE VACCINES THAT INDUCE ANTIBODIES AGAINST CANCER .2. PREVIOUS EXPERIENCE AND FUTURE-PLANS
Authors:
LIVINGSTON PO
RAGUPATHI G
Citation: Po. Livingston et G. Ragupathi, CARBOHYDRATE VACCINES THAT INDUCE ANTIBODIES AGAINST CANCER .2. PREVIOUS EXPERIENCE AND FUTURE-PLANS, Cancer immunology and immunotherapy, 45(1), 1997, pp. 10-19
Authors:
MULLINS DW
WALKER TM
BURGER CJ
ELGERT KD
Citation: Dw. Mullins et al., TAXOL-MEDIATED CHANGES IN FIBROSARCOMA-INDUCED IMMUNE CELL-FUNCTION -MODULATION OF ANTITUMOR ACTIVITIES, Cancer immunology and immunotherapy, 45(1), 1997, pp. 20-28
Authors:
SIZIOPIKOU KP
AHN MC
CASEY L
SILVER M
HARRIS JE
BRAUN DP
Citation: Kp. Siziopikou et al., AUGMENTATION OF IMPAIRED TUMORICIDAL FUNCTION IN ALVEOLAR MACROPHAGESFROM LUNG-CANCER PATIENTS BY COCULTIVATION WITH ALLOGENEIC, BUT NOT AUTOLOGOUS LYMPHOCYTES, Cancer immunology and immunotherapy, 45(1), 1997, pp. 29-36
Authors:
AHN MC
SIZIOPIKOU KP
PLATE JMD
CASEY L
SILVER M
HARRIS JE
BRAUN DP
Citation: Mc. Ahn et al., MODULATION OF TUMORICIDAL FUNCTION IN ALVEOLAR MACROPHAGES FROM LUNG-CANCER PATIENTS BY INTERLEUKIN-6, Cancer immunology and immunotherapy, 45(1), 1997, pp. 37-44
Authors:
BRUSERUD O
PAWELEC G
Citation: O. Bruserud et G. Pawelec, INTERLEUKIN-13 SECRETION BY NORMAL AND POSTTRANSPLANT T-LYMPHOCYTES -IN-VITRO STUDIES OF CELLULAR IMMUNE-RESPONSES IN THE PRESENCE OF ACUTE-LEUKEMIA BLAST CELLS, Cancer immunology and immunotherapy, 45(1), 1997, pp. 45-52
Authors:
OGOSHI K
TAJIMA T
MITOMI T
MAKUUCHI H
TSUJI K
Citation: K. Ogoshi et al., HLA-A2 ANTIGEN STATUS PREDICTS METASTASIS AND RESPONSE TO IMMUNOTHERAPY IN GASTRIC-CANCER, Cancer immunology and immunotherapy, 45(1), 1997, pp. 53-59
Authors:
KRAWCZYK CM
VERSTOVSEK S
UJHAZY P
MACCUBBIN D
EHRKE MJ
Citation: Cm. Krawczyk et al., PROTECTIVE SPECIFIC IMMUNITY INDUCED BY CYCLOPHOSPHAMIDE PLUS TUMOR-NECROSIS-FACTOR-ALPHA COMBINATION TREATMENT OF EL4-LYMPHOMA-BEARING C57BL 6 MICE (VOL 40, PG 347, 1995)/, Cancer immunology and immunotherapy, 45(1), 1997, pp. 60-60
Authors:
MOURI T
NAKAMURA S
OHYAMA Y
MATSUZAKI G
SHINOHARA M
KISHIHARA K
HIROKI A
OKA M
SHIRASUNA K
NOMOTO K
Citation: T. Mouri et al., T-CELL RECEPTOR V-ALPHA AND V-BETA GENE USAGE BY TUMOR-INFILTRATING LYMPHOCYTES IN ORAL SQUAMOUS-CELL CARCINOMA (VOL 43, PG 10, 1996), Cancer immunology and immunotherapy, 45(1), 1997, pp. 61-61